Magmitt Safety Questions, Magmitt Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Magmitt side effects. Check out Health Surveys and Health Polls. If you have questions about Magmitt, you can post them to our Doctors or Ask Patient Community about Magmitt.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Magmitt
Magmitt Safety Reports
Total Magmitt reports: 6.Magmitt FDA safety alerts: No.
Reported hospitalizations: 4.
Take Magmitt Side Effects Survey or Share Your Magmitt Story.
Reported Magmitt Side Effects: hepatic function abnormal, haematocrit decreased, gamma-glutamyltransferase abnormal, blood urea increased, blood lactate dehydrogenase increased, blood creatinine increased, blood alkaline phosphatase increased, aspartate aminotransferase increased, anuria, alanine aminotransferase increased, white blood cell count decreased.
More About Magmitt.
Magmitt Side Effects Report #5295123-1
Health Professional from JAPAN reported MAGMITT problem on Apr 03, 2007. Male patient, weighting 145.5 lb, was diagnosed with cerebrovascular disorder and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. MAGMITT dosage: 1800 MG. During the same period patient was treated with GASTER D, ALEVIATIN, CLOPIDOGREL. Patient was hospitalized. Patient recovered.
Magmitt Side Effects Report #5304822-4
MAGMITT problem was reported by a Health Professional from JAPAN on Apr 17, 2007. Male patient, weighting 145.5 lb, was diagnosed with cerebrovascular disorder and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. MAGMITT dosage: 1800 MG. During the same period patient was treated with GASTER D, ALEVIATIN, CLOPIDOGREL. Patient was hospitalized. Patient recovered.
Magmitt Side Effects Report #5349335-9
Health Professional from JAPAN reported MAGMITT problem on May 28, 2007. Male patient, weighting 145.5 lb, was diagnosed with cerebrovascular disorder and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. MAGMITT dosage: 1800 MG. During the same period patient was treated with GASTER D, ALEVIATIN, CLOPIDOGREL. Patient was hospitalized. Patient recovered.
Magmitt Side Effects Report #5050977-9
MAGMITT problem was reported by a Physician from JAPAN on May 30, 2006. Male patient, 57 years of age, weighting 121.3 lb, was diagnosed with metastases to bone and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase abnormal, haematocrit decreased. MAGMITT dosage: 1500 MG/D. During the same period patient was treated with MARZULENE S, SOLANAX, AMOBAN, LOXONIN, OXYCONTIN, ZOMETA. Patient recovered.
Magmitt Side Effects Report #5128902-1
Health Professional from JAPAN reported MAGMITT problem on Oct 05, 2006. Male patient, weighting 125.7 lb, was diagnosed with ill-defined disorder, hypertension and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: cough, dysphagia, granulocytopenia, pneumonia, pyrexia, white blood cell count decreased. MAGMITT dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, WARFARIN, PURSENNID. Patient was hospitalized. Patient recovered.
Magmitt Side Effects Report #5153042-5
MAGMITT problem was reported by a Physician from JAPAN on May 30, 2006. Male patient, 57 years of age, weighting 121.3 lb, was diagnosed with metastases to bone and was treated with MAGMITT. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase abnormal, haematocrit decreased. MAGMITT dosage: 1500 MG/D. During the same period patient was treated with MARZULENE S, SOLANAX, AMOBAN, LOXONIN, OXYCONTIN, ZOMETA. Patient recovered.